Types of progestogens in combined oral contraception: effectiveness and side‐effects

TA Lawrie, FM Helmerhorst, NK Maitra… - Cochrane Database …, 2011 - cochranelibrary.com
Background The progestogen component of combined oral contraceptives (COC) has
undergone changes since it was first recognised that it's chemical structure could influence …

Contraception and headache

EA MacGregor - Headache: The Journal of Head and Face …, 2013 - Wiley Online Library
Most women have used at least 1 method of contraception during their reproductive years,
with the majority favoring combined oral contraceptives. Women are often concerned about …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …

J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …

Gestodene: a review of its pharmacology, efficacy and tolerability in combined contraceptive preparations

MI Wilde, JA Balfour - Drugs, 1995 - Springer
The newer progestogens gestodene, desogestrel and norgestimate were developed in an
attempt to produce agents with more selective progestational activity that would improve …

Effectiveness and acceptability of progestogens in combined oral contraceptives–a systematic review

R Kulier, FM Helmerhorst, N Maitra, AM Gülmezoglu - Reproductive health, 2004 - Springer
Background The progestogen component of oral contraceptives (OCs) has undergone
changes since it was recognized that their chemical structure can influence the spectrum of …

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical study

J Endrikat, B Düsterberg, A Ruebig, C Gerlinger… - Contraception, 1999 - Elsevier
This study compares the contraceptive reliability, cycle control, and tolerability of two oral
contraceptive preparations containing 20 μg of ethinyl estradiol combined with either 75 μg …

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol …

J Endrikat, MA Jaques, M Mayerhofer, C Pelissier… - Contraception, 1995 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …

A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives

V Bruni, H Croxatto, J De La Cruz, M Dhont… - Gynecological …, 2000 - Taylor & Francis
This was an open-label multicenter study to compare the cycle control and effect on well-
being of two oral contraceptives containing gestodene and one containing desogestrel. A …

Efficacy and acceptability of two monophasic oral contraceptives containing ethinylestradiol and either desogestrel or gestodene

HW Halbe, NR De Melo, L Bahamondes… - … European Journal of …, 1998 - Taylor & Francis
Objective To assess the contraceptive efficacy, cycle control and acceptability of two
monophasic oral contraceptives containing either 30 µg ethinylestradiol plus 150 µg …

The effects of a low-dose gestodene-containing oral contraceptive on endometrial histology in healthy women

CMH Coenen, JMG Hollanders, R Rolland… - … European Journal of …, 1996 - Taylor & Francis
Objective In women who use oral contraceptives with low estrogen doses, a quiescent
endometrium is frequently produced. Further reduction of the estrogen dose would not be …